Interferon-Alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia - Contacts and Locations

Interferon-Alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00002868. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002868

Locations


United States, New Jersey
	Hackensack University Medical Center
	Hackensack, New Jersey, United States, 07601
	Riverview Medical Center - Booker Cancer Center
	Red Bank, New Jersey, United States, 07701

United Kingdom, Scotland
	Royal Infirmary
	Glasgow, Scotland, United Kingdom, G4 0SF

Sponsors and Collaborators

Medical Research Council

National Cancer Institute (NCI)

Eastern Cooperative Oncology Group

Investigators


Study Chair:	Ian M. Franklin, MB, PhD	Royal Infirmary - Castle

Study Chair:	Hillard M. Lazarus, MD	Case Comprehensive Cancer Center